-
1
-
-
33749446478
-
Surgical management of renal cell carcinoma
-
Leibovich BC, Blute ML. Surgical management of renal cell carcinoma. Semin Oncol. 2006;33:552-562.
-
(2006)
Semin Oncol
, vol.33
, pp. 552-562
-
-
Leibovich, B.C.1
Blute, M.L.2
-
2
-
-
0042320473
-
The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma
-
Wood CG. The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma. Urol Clin North Am. 2003;30:581-588.
-
(2003)
Urol Clin North Am
, vol.30
, pp. 581-588
-
-
Wood, C.G.1
-
3
-
-
0035934596
-
Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renalcell carcinoma: A randomised trial
-
Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renalcell carcinoma: a randomised trial. Lancet. 2001;358:966-970.
-
(2001)
Lancet
, vol.358
, pp. 966-970
-
-
Mickisch, G.H.1
Garin, A.2
Van Poppel, H.3
-
4
-
-
0035818877
-
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
-
DOI 10.1056/NEJMoa003013
-
Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345:1655-1659. (Pubitemid 33126820)
-
(2001)
New England Journal of Medicine
, vol.345
, Issue.23
, pp. 1655-1659
-
-
Flanigan, R.C.1
Salmon, S.E.2
Blumenstein, B.A.3
Bearman, S.I.4
Roy, V.5
McGrath, P.C.6
Caton Jr., J.R.7
Munshi, N.8
Crawford, E.D.9
-
5
-
-
33748569461
-
Prognostic factors in metastatic renal cell carcinoma: Metastasectomy as independent prognostic variable
-
Vogl UM, Zehetgruber H, Dominkus M, et al. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable. Br J Cancer. 2006;95:691-698.
-
(2006)
Br J Cancer
, vol.95
, pp. 691-698
-
-
Vogl, U.M.1
Zehetgruber, H.2
Dominkus, M.3
-
6
-
-
41449093920
-
Adjuvant approaches to renal cell carcinoma
-
Wood CG. Adjuvant approaches to renal cell carcinoma. Clin Adv Hematol Oncol. 2008;6:19-21.
-
(2008)
Clin Adv Hematol Oncol
, vol.6
, pp. 19-21
-
-
Wood, C.G.1
-
7
-
-
33846850577
-
Adjuvant therapy for high-risk renal cell carcinoma patients
-
Kunkle DA, Haas NB, Uzzo RG. Adjuvant therapy for high-risk renal cell carcinoma patients. Curr Urol Rep. 2007;8:19-30.
-
(2007)
Curr Urol Rep
, vol.8
, pp. 19-30
-
-
Kunkle, D.A.1
Haas, N.B.2
Uzzo, R.G.3
-
8
-
-
0030751476
-
Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma
-
DOI 10.1016/S0022-5347(01)64091-6
-
Walther MM, Yang JC, Pass HI, et al. Cytoreductive surgery before high dose interleukin-2 based therapy in patients with metastatic renal cell carcinoma. J Urol. 1997;158:1675-1678. (Pubitemid 27433129)
-
(1997)
Journal of Urology
, vol.158
, Issue.5
, pp. 1675-1678
-
-
Walther, M.M.1
Yang, J.C.2
Pass, H.I.3
Linehan, W.M.4
Rosenberg, S.A.5
-
9
-
-
33846519375
-
Presurgical therapy in metastatic renal cell carcinoma
-
Jonasch E. Presurgical therapy in metastatic renal cell carcinoma. Expert Rev Anticancer Ther. 2007;7:73-78.
-
(2007)
Expert Rev Anticancer Ther
, vol.7
, pp. 73-78
-
-
Jonasch, E.1
-
10
-
-
33846867459
-
Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: Combining surgery and systemic therapies to improve patient outcome
-
Wood CG. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome. Clin Cancer Res. 2007;13:697s-702s.
-
(2007)
Clin Cancer Res
, vol.13
-
-
Wood, C.G.1
-
11
-
-
44649192971
-
Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma
-
Margulis V, Matin SF, Tannir N, et al. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma. J Urol. 2008;180:94-98.
-
(2008)
J Urol
, vol.180
, pp. 94-98
-
-
Margulis, V.1
Matin, S.F.2
Tannir, N.3
-
12
-
-
39449121694
-
Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi
-
Karakiewicz PI, Suardi N, Jeldres C, et al. Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol. 2008;53:845-848.
-
(2008)
Eur Urol
, vol.53
, pp. 845-848
-
-
Karakiewicz, P.I.1
Suardi, N.2
Jeldres, C.3
-
13
-
-
50049092572
-
Neoadjuvant targeted therapy and advanced kidney cancer: Observations and implications for a new treatment paradigm
-
Shuch B, Riggs SB, Larochelle JC, et al. Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm. BJU Int. 2008;102:692-696.
-
(2008)
BJU Int
, vol.102
, pp. 692-696
-
-
Shuch, B.1
Riggs, S.B.2
Larochelle, J.C.3
-
14
-
-
42249091688
-
Sunitinib for treatment of advanced renal cell cancer: Primary tumor response
-
van der Veldt AA, Meijerink MR, van den Eertwegh AJ, et al. Sunitinib for treatment of advanced renal cell cancer: primary tumor response. Clin Cancer Res. 2008;14:2431-2436.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2431-2436
-
-
Van Der Veldt, A.A.1
Meijerink, M.R.2
Van Den Eertwegh, A.J.3
-
15
-
-
0032883614
-
Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place
-
DOI 10.1097/00005392-199907000-00011
-
Wagner JR, Walther MM, Linehan WM, et al. Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place. J Urol. 1999;162:43-45. (Pubitemid 29420876)
-
(1999)
Journal of Urology
, vol.162
, Issue.1
, pp. 43-45
-
-
Wagner, J.R.1
Walther, M.M.2
Linehan, W.M.3
White, D.E.4
Rosenberg, S.A.5
Yang, J.C.6
|